Gliolan® is taken orally by the patient prior to surgery. In combination with a specialist surgical microscope and blue light source, Gliolan® fluoresces the malignant part of the tumour enabling the surgeon to make a distinction between malignant and normal tissue.
Gliolan® can be used by neurosurgical units with the necessary microscopic equipment and staffed by experienced, authorised neurosurgeons in line with European Medicines Agency (EMA) regulations.
Using Gliolan® requires special training. For information on this click below.